Skip to main content
Caplight Logo









Pylum Biosciences, Inc.

Pylum Biosciences, Inc.

Private
San Carlos, CaliforniaHealthcare & Life Scienceshttps://pylumbio.com/

Last Round

Seed

Mar 5, 2020

Total Funding Raised

$962,000

Company Overview

Pylum Biosciences, Inc. is a biotechnology company that develops precision anti-bacterial technology and bactericidal protein complexes targeting specific bacterial pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

precision antibacterialsprotein engineeringbactericidal proteinsantibiotic resistancephage therapynarrow-spectrum antibioticsdrug discoverybiotechnologyinfectious diseasemicrobiome therapeuticsbiodefensepreclinical developmentdrug-resistant pathogenssuperbug treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pylum Biosciences, Inc. Comparables

Compare Pylum Biosciences, Inc. with similar companies based on industry and business-model similarity.

Pylum Biosciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eligo Bioscience
82%
Locus Biosciences
81%
BiomX Inc.
74%

Pylum Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 5, 2020
GrantJan 28, 2019

Pylum Biosciences, Inc. Investors

Notable investors and investment history

Pylum Biosciences, Inc. investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2024

    Grew 300% QoQ from 1 to 4 employees.

  • Mar 5, 2020

    $990K raised in Seed round.

Pylum Biosciences, Inc. Filings

Explore SEC and related filing metadata, where available.

Pylum Biosciences, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pylum Biosciences, Inc.'s valuation, stock price, and market status.

Is Pylum Biosciences, Inc. a public or private company?

Pylum Biosciences, Inc. is a private company.

What is the current stock price of Pylum Biosciences, Inc.?

Pylum Biosciences, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Pylum Biosciences, Inc. worth (valuation)?

Valuation information for Pylum Biosciences, Inc. is not publicly available.

Can I buy Pylum Biosciences, Inc. stock?

Pylum Biosciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pylum Biosciences, Inc.'s last funding round?

Pylum Biosciences, Inc.'s most recent funding round was Seed on March 5, 2020.

Who are the main investors in Pylum Biosciences, Inc.?

Key investors in Pylum Biosciences, Inc. include National Institute of Allergy and Infectious Diseases.

Will Pylum Biosciences, Inc. IPO soon?

No public IPO plans have been announced for Pylum Biosciences, Inc..

How can I track Pylum Biosciences, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pylum Biosciences, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Carlos, California
Employee Range3
Year Founded2016
Last FundingMar 5, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?